MT Group

MT Group is an active, independent contract research organization (CRO) specializing in customized biospecimen collection and biorepository services for pharmaceutical, biotechnology, and diagnostic companies. They support R&D by providing high-quality human tissue and biological samples—such as fresh/frozen/FFPE tissue, blood components, swabs, urine, saliva—with comprehensive clinical annotation ("MT Level" metadata). Their collections span oncology (over half of their work), autoimmune diseases (notably inflammatory bowel disease, psoriatic arthritis, atopic dermatitis), NASH, cardiology, COVID‑19 research and more. They operate through an extensive global site network (>150 sites) with access to thousands of patients across diverse populations. Founded in 2003 by Dr. Tom Moss in Los Angeles[1][2][3][4], they are recognized for quality assurance and deep client partnerships supporting translational research[1][2][3].